sh-Polypeptide-12

Functions
Soothing
Anti-histamin
Anti-psoriasis
Regeneration booster
FDA UNII
4I7AHS3FPJ
INCI name
sh-Polypeptide-12
Identifier
CIG-1511
Origin
Synthetic

sh-Polypeptide-12 is a synthetic recombinant single-chain peptide, an analog of human Interleukin 4 (IL-4), that acts as an antihistamine or immune-suppressor agent to reduce scratching by inhibiting the autoimmune response. It is known under the trade name CG-IL-4; the former INCI designation was Human Oligopeptide-15 (rh-Oligopeptide-15).

sh-Polypeptide-12 lessens skin irritation on the lower part of the legs, which is generally related to circulatory problems. It is effective against psoriasis, an autoimmune condition in which the immune system produces too many immune cells. IL-4 treatment decreases PASI (Psoriasis Area and Severity Index).

In vivo studies showed that sh-Polypeptide-12 activates and induces the proliferation of dermal fibroblasts, enhances the production of GAGs, collagen, and decorin, and accelerates wound healing. Targeted therapies with rh-IL-4 showed promising results in reducing chronic dermal inflammation.

Studies have shown that IL-4 can reduce the production of filaggrin, loricrin, and involucrin, which are involved in skin hydration and barrier function, via the IL-4Rα signaling pathway, a pattern typical of Atopic Dermatitis. Thus, individuals prone to Atopic Dermatitis should use skincare products containing sh-Polypeptide-12 (IL-4-mimetic) with caution and consult a physician if they experience adverse reactions or changes in skin condition.
Synonyms
rh-Polypeptide-12
CG-IL-4
Human Oligopeptide-15
rh-Oligopeptide-15
rh-IL-4
Changed

References

  1. Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts
    Author(s):
    , , ,
    PMID:
    1611720
    DOI:
    10.1016/0090-1229(92)90011-c
  2. Stimulation of sulphated glycosaminoglycan and decorin production in adult dermal fibroblasts by recombinant human interleukin-4
    Author(s):
    , , , , ,
    PMID:
    7741696
    DOI:
    10.1042/bj3070673
  3. Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model
    Author(s):
    , , , , , , ,
    PMID:
    19729876
    DOI:
    10.1159/000235974
  4. Interleukin-4 (IL-4) enhances and soluble interleukin-4 receptor (sIL-4R) inhibits histamine release from peripheral blood basophils and mast cells in vitro and in vivo
    Author(s):
    , , , , ,
    PMID:
    18472844
    DOI:
    10.1080/09629359791802
  5. An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip
    Author(s):
    , ,
    PMID:
    35216228
    DOI:
    10.3390/ijms23042116